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Alkaline phosphatase (APase) exhibits phosphohydrolase 
actiVity toward some phosphate monoesters at an alkaline pH. 
This enzyme has also been shown to demonstrate phosphotrans-
ferase (transphosphorylase) activity from the phosphoryl-en-
zyme to an acceptable nucleophile. 
The effect of some polar, nonpolar and basic amino acids 
on the activity of APase was studied spectrophotometrically. 
All were found to cause inhibition of the enzyme activity at 
varying degrees vrith 1-homoarginine having the largest inhibi-
tory influence on the APase activity. L-llomoarginine, having 
iii 
the largest effect, was thus selected to carry out further 
kinetic studies in diethanolamine and carbonate buffers. L-
· Homoarginine was found to be an 11uncompetitive" inhibitor of 
APase activity. It was speculated from these investigations 
that L-homoarginine inhibits the dephosphorylation of APase in 
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Alkaline phosphatase (orthophosphate monoester phospho-
hydrolase}, as the name implies, is an enzyme that cleaves 
phosphate monoesters at an alkaline pH. The enzyme also demon-
strates phosphotransferase activity. 
The physiological role of alkaline phosphatase (APase} has 
not yet been discerned, but the enzyme may be involved in the 
transport of phosphates through the cell membrane. The appear-
ance of APase seems sensitive to the amount of inorganic phos-
phate present. When ~ £211 cells were grown under phosphate 
deprived conditions about 6% of the total protein synthesized 
was APase (Garen and Levinthal, 1960}. A decrease in inor-
ganic phosphate in the rat renal cell caused noticeable in-
creases in APase activity. This regulation by inorganic 
phosphate was abolished by inhibitors of protein or nucleic 
acid synthesis, indicating that the response was dependent on 
S!, !!2!2, synthesis of both RNA and protein (Helani, et al., 
1967). Thus APase may function in the regulation of phosphate 
in the cell. 
!lore attentj_on was focused on APase when Fishman et al. 
1 
2 
(1968) discovered a human placental APase isozyme was present 
in the serum and tumor tissue of a patient with lung cancer. 
Hany other investigators continued the study of the relation-
ship of APase of fetal and neoplastic origin. Elson and Cox 
(1969) revealed that similar immunological and electrophoreti-c 
properties existed between fetal APase from human placenta and 
HeLa cell APase. One possible explanation of why a cell be-
comes cancerous is through a derepression of the cells normal 
function and a reversion to an immature rapidly dividing cell. 
Attempts have been made to use APase as a tool in the 
detection of cancer. Hethods now exist to distinguish differ-
ent isozymes of APase. Many reports in the literature have 
claimed the indentification of APase isozymes by the inhibi-
tory effect Of various compounds. Kellen and Lustig (1971) re-
ported that the inhibitory effect of several amino acids in-
creased in APase of tumor cells over that of the normal cells 
regardless of their histological type. This thesis includes 
results on amino acid inhibition studies of murine placental 
APase. It is hoped that one day a correlation will be found to 
exist between the inhibitory effect of amino acids on placen-
tal tissue and tissue of neoplastic origin. 
CHAPI'ER II 
REVIEW OF LITERATURE 
Monesterified phosphates as well as deoxriboligonucleo-
tides irrespective of chain length were susceptable to the 
activity of purified human placental APase. The purified en-
zyme exhibited phosphotransferase activity when nucleosides and 
mononucleotide& were employed as acceptors and donors respec-
tively (Georgatosos, 1967). Myerhof and Green (1950) reported 
that nucleotide& were not necessary for transphosphorylation by 
APase and that direct phosphate transfer could occur with APase 
and some common biological poly-alcohols (glucose, fructose and 
glycerol) in the presence of phosphocreatine, phosphopyruvate 
and glucose !-phosphate labelled with p32• Studies on various 
other phosphate acceptors have been made. Certain aminated al-
cohols, especially 2-ethylaminoethanol (EAE) and diethanola-
mine (DEA) activated the human APase activity toward certain 
phosphorylated substrates while buffering the reaction (Amador 
and Urban, 1972). Hydroxyl compow:ds conta:tnj_ng either a se-





than 1, .3 enhanced !t_ ~ APase activity over hydroxyl com-
pounds with smaller or larger distances between these groups 
(Wilson, et al., 1964). Besides human and !t_ .£21! APase, APase 
from calf intestinal mucosa and from cows• milk also catalyzed 
the synthesis of phosphate esters by direct transfer of the 
phosphate group from phosphomonoesters to suitable hydroxyl 
compounds (Morton, 1958). It is therefore reasonable to assume 
that most alkaline phosphatases exhibit phosphotransferase ac-
tivity as well as phosphohydrolase activ:i.ty. 
The phosphotransferase activity occurs with the dephos-
phorylation of the phosphoryl-enzyme complex which is formed 
and is deemed the rate-determining step of the reaction by 
Fernley and Walker (1966). Evidence of the formation of this 
phosphorylenzyme complex is provided by data on !t_ £21! and 
calf intestinal APase. EngstrOm (1961) reported the incorpora-
tion of p32 into highly purified calf intestinal APase by the 
isolation of radioactive phosphorylaerine. He reported no p32 
incorporation by the inactivated enzyme. Sch\'lartz and Liproan 
(1961) carried out si~ilar studies on !t_ ~ APase. Highly 
purified E. coli APase reacted with radioactive inorganic 
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phosphate yielding serine phosphate and serine phosphate con-
taining peptides upon parial acid hydrolysis of the enzyme. 
After further digestion of the enzyme with trypsin only one ma-
jor component appeared containing the p32• This product was 
degraded by acid hydrolysis to serine phosphate. Therefore, 
these investigators concluded that of the thirty three serine 
molecules known to be present in the phosphatase only a partic-
ular one reacts with the phosphate. This phosphate bonding 
serine is probably the active site of the enzyme. 
Although APase hydrolyzes a broad range of phosphate mo-
noesters, the inhibition of different isozymes may demonstrate 
substrate specificity. Substrates such as sodium beta-glycero-
phosphate, adenosine 3'-phosphate, glucose 1-phosphate, etc. 
had similar reaction velocities while ATP, creatine phosphate 
and sodium pyrophosphate showed little reaction when exposed 
to ~ ~ APase (Garen and Levinthal, 1960). Differences in 
the percent inhibition by L-phenylalanine of intestinal APase 
occurred in five phosphomonoesterases compared as substrates 
in a study carried out by Vlatanabe and Fishman (1964). L-
Phenylalanine was found not to inhibit intestinal APase when 
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para-nitrophenyl phosphate was used as a substrate, while in-
hibition occured when phenyl phosphate was used as a substrate 
( Keiding 1 1966). Casey and Laidler (1950) attributed a posi-
tive change in entropy in an enzymatic reaction to a conforma-
tional change in the enzyme molecule during the reaction. 
Positive entropy changes which varied from substrate to sub-
strate led Nath in 1966 to postulate that the APase molecule 
experienced a conformational change when it formed complexes 
with the substrates. The conformational change that occured 
was influenced by the electron displacement of the substituent 
in the substrate molecule. The kind of substrate employed 
seems important since in localization studies or APase activi-
ty in liver and intestine using L-homoarginine and L-phenyla-
lanine to inhibit respectively, sensiUvity to the inhibitor 
depended on the type substrate used (Rufo and Fishman, 1972). 
Several investigators have reported inhibition of various 
isozymes of APase by amino acids. The activity of leucocyte 
APase was inhibited by a nurr,ber of amino acids with cysteine 
and histidine inhibiting the greatest (DeChatelet 1 et al., 
1971). DoeJJge.st and Fishman (1976) found leucine to be a 
7 
specific inhibitor of a rare human placental APase. Most 
studies have been focuE;ed on L-tryptophan, L-phenylalanine and 
L-homoarginine inhibition. L-Tryptophan inhibited human pla-
cental and intestinal APase uncompetitively but did not inhibit 
liver and bone APase (Lin, et al., 1971). Its behavior was 
similar to L-phenylalanine which was also a specific uncompeti-
tive inhibitor of human placental and intestinal APase. The 
integrity of the phenyl ring in L-phenylalanine and the in-
dolyl ring in L-tryptophan as well as their alpha amino groups 
were essential for the inhibition to occur (Fishman and Sie, 
1971). L-Homoarginine served as an uncompetitive inhibitor for 
bone and liver APase but not placental and intestinal human 
isozymes of APase accordj.ng to Fishman and Sie (1970). They 
stated that the alkyl hydrocarbon chain and the imino group 
appeared to be structural requirements for the inhibj_tion since 
L-homocitrulline, L-canavanine and guanine were not inhibitors 
of bone and liver APase. 
Inhibition by L-homoarginine decreased with increasing 
temperature. A shift toward a higher optimal temperature for 
Vmax in the presence of the inhibitor indicated the binding 
8 
of the inhibitor to the enzyme-substrate complex. This may have 
caused a change in the enzyme molecule to a more thermostable 
conformation or the inhibitor may have stabilized the enzyme in 
its active form (Lin and Fishman, 1972). McElroy et al. (1967) 
suggested that the binding of the inhibitor to the active site 
of the enzyme caused a conformational change in the protein and 
led to a modification of the bound intermediate. This was in 
contrast to the allosteric mechanism where the mo~fier mole-
cule combines at a site other than the active center. In order 
to determine the number of inhibitor molecules bound to the ac-
tive site of the complex Taketa and Pogell (1965) plotted the 
log of the percent inhibition versus the log of the inhibitor 
concentration. The graph provided parallel straight lines 
whose slopes were equal to the n value, which is the apparent 
number of inhibitor molecules combining with one enzyme mole-
cule. Using this method Lin et al. (1971) determined n for 
APase to be equal to one for L-tryptophan and for L-homoargi-
nine (Lin and Fishman, 1972). 
Because of the enzyme-substrate complex appearing to be 
the site of attachment for the inhibitor in uncompetitive 
I . 
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inhibition many theories have been proposed to explain the 
formation of the complex and thereby the overall APase mecha-
nism. Ghosh and Fishman (1966) initially proposed the forma-
tion of a poorly dissociable enzyme-inhibitor-substrate com-
plex for the mechanism of APase inhibition by L-phenylalanine. 
Later Fernley and Walker (1970) suggested that the inhibitor 
prevented the breakdown of the subsequently formed phosphoryl-
enzyme intermediate rather than acting on the enzyme-substrate 
complex. Lin et al. (1971) felt that the inhibitor may have 
blocked the hydrolysis step in the conversion of the enzyme-
substrate-inhibitor complex into the phosphoryl-enzyme-sub-
strate-inhibitor complex. 
CHA?rER III 
MATERIALS AND METHODS 
A. Enzyme Source and Preparation 
The source of APase was placental tissue from 16 day 
pregnant mice. The mice were inbred C57Bl/ka originally ob-
tained from Dr. Henry Kaplan at Stanford University. 
The tissue was removed surgically and pressed through 
a wire mesh into cold 0.05 M Tris-HCl buffer at pH 7•4 con-
taining 0.15 M NaGl with a concentration of five placentae 
per milliliter of buffer. This cell suspension was centri-
fuged at 49,000 rpm for 1 hour at 4° c. The supernatant was 
removed and the pellet homogenized with 1% NP40 detergent, 
incubated at 45° C for 30 minutes and again centrifuged. The 
NP40 treatment was repeated three times. Each time the su-
pernatant containing membrane fragments was reserved. The 
supernatants were pooled and APase was extracted from the 
membrane by slowly adding, with stirring, cold n-butanol. 
When a concentration of 30% butanol in the supernatant was 
reached the mixture was again centrifuged for 1 hour at 
49,000 rpm. The supernatant containing the enzyme was dia-
lyzed against distilled water for approximately 36 hours 
with frequent changes. The dialyzed enzyme extract vras con-
centrated and stored at -4° G. The enzyme remained stable 




Various concentrations of carbonate and diethanolamine 
(DEA) buffers were employed in the assays. Amino acids, when 
required, were added to the buffers before the pH was adjusted. 
DEA was adjusted to pH 10 at 37° C with NaOH. The pH of the 
carbonate buffers was adjusted to pH 10 at 37° C by mixing 
sodium carbonate and sodium bicarbonate solutions of the same 
concentration. 
c. Enzyme Assay 
The 1 ml enzyme assay volume consisted of 0.1 ml tissue 
extract (APase source) at an appropriate concentration, 0.1 ml 
of substrate, which was para-nitrophenyl phosphate (p-NPP), 
and 0.8 ml of buffer. The activity of the enzyme or the ve-
locity of the reaction was determined according to the amount 
of colorless p-NPP hydrolyzed to para-nitrophenol (p-NP). 
Since p-NP is yellow, it was measured spectrophotometrically 
at 400 nm. The Hitachi Digital Spectrophotometer Hodel 102 
with N-23 Kinetic Timer and N-25 Sampler/Temperature Control-
ler was adjusted from the standard curve to read the concen-
tration of p-NP at any given absorbance. Readings were then 
taken as the number of micromoles of p-NP produced per minute 




A. Effect of L-Amino Acids 
L-Amino acids at 10 mM concentrations from three of the 
four major classes of amino acids were tested in 0.1 M DEA to 
determine the effect on APase activity. Amino acids contain-
ing acidic groups were not tested because of the high pH re-
quirement for the enzyme. 
Those amino acids with uncharged polar groups (Table 1) 
demonstrated the smallest inhibitory effect on APase activity 
of the three classes examined. The members of this group 
all showed less than 13% inhibition. 
Amino acids with nonpolar groups (Table 2) comprised 
the second major class investigated. The inhibition of APase 
activity by this class ranged from 12.83% by proline to 32.89% 
by leucine with an average inhibition of 24.28%. Alanine 
was the exception in this group with an inhibition of only 
3.06%. 
The greatest inhibition of APase activity was displayed 
by amino acids containine basic groups (Table 3). The aver-
age inhibition by this class was 32.91% with the exception of 
L-homoarginine 1 which inhibited APase activj_ty hy 77.22%. 
B. Inhibition Pattern of L-Homoarginine 




Inhibition of Alkaline Phosphatase Activity 
by Uncharged Polar Amino Acids 
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6-44 .!. 2.02 
7-76 .!. 2.68 
12.57 + 4·79 
12.91 .:!:. 2.52 




Inhibition of Alkaline Phosphatase Activity 
by Nonpolar Amino Acids 









3.06 .!. 4.20 
12.83 .!. 4·94 
19.86 .!. 4·42 
21.51 .!. 0.78 
25·95 .!. 3·09 
32.61 .!. 1.85 
32.89 .!. 0.07 
~ean and standard deviation of at least three experiments 
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TABLE 3 
Inhibition of Alkaline Phosphatase Activity 
by Basic Amino Acids 





29-51 + 1.22 -
30.53 :!:. 3.62 
38.69 :!:. 3.12 
77.22 :!:. 0.93 
~ean and standard deviation for at least three experiments 
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versus the inverse of the reaction velocity with zero, J. mM, 
2.5 mH and 5.0 mM concentrations of L-homoarginine demon-
strated parallel lines increasing with inhibitor concentra-
tion. This pattern remained consistent in 0.1 H Carbonate 
(Figure 1), 0.1 M DEA (Figure 2) and 1.0 M,DEA (Figure 3) 
buffers. This three ngures show typical patterns of "un-
COlllpetitive" inhibition in which the slope of the plots re-
mains constant and Vmax decreases in increasing concentra-
tions of the inhibitor. 
The overall velocity of the reaction was lowest in 
0.1 M Carbonate buffer; since it does not activate APase ac-
tivity and is considered neutral. Diethanolamine, a nu-
cleophilic buffer activates APase activity and therefore the 
reaction velocity was higher in 0.1 M DEA and the highest in 
1.0 M DEA. 
C. Effect of Diethanolamine 
Since DEA serves as a second substrate for Arase, plots 
of the inverse of DEA concentration versus the inverse of the 
reaction velocity were 111ade ·.;fi th high (Figure 4) and low 
(Figure 5) DEA concentrations to display the effect of in-
creasing inhibitor concentrations. The inhibition mechanis~ 
with L-homoarginine was clearl:,· "cor·cpeti ti ve" in the graph of 
high DEA concentrations. A mixed 1~echanism was shown by the 
graph of L-ho::oar:-;inj 1:c :in J.ov: lJI~l\ concentrations. 
FiE~. 1. Lineweaver-Burk plot of L-homoarginine inhibition 
jn o.J r: carbonate. 
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Fig. 2. Lineweaver-Durk plot of L-homoarginine inhibition 
in 0.1 M diethanolamine 
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Fig. Lineweaver-Burk plot of L-homoarginine inhibition 
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Fig. 5· Lineweaver-Burk plot of L-homoarginine inhibition 
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CHAPTER V 
DISCUSSION 
A ping pong bi bi mechanism is proposed for alkaline 
phosphatase (Figure 6). The enzyme hydrolyzes the para-
nitrophenyl phosphate to para-nitrophenol with the enzyme 
becoming phosphorylated. The phosphate group is then 
transferred by the enzyme to a nucleophile leaving the en-
zyme free to combine again with the substrate. 
After the APase enzyme becomes phosphorylated by hy-
drolysis of the firr;t Gubstrate an attack begins on the 
phosphorus atom attached to the nucleophilic group of serine 
in the actj_ve center of the enzyme. The attack is made by 
endogenous nucleophiles (water) or those nucleophilic groups 
provided by the aminated alcohol (DEA). The larger the num-
ber of nucleophiles present to accept the phosphate the 
greater the Vmax of the reaction. The enzyme activity was 
three times higher in 1.0 M DEA than in 0.1 M DEA. In the 
carbonate buffered reaction water served as the nucleophile 
and the activity was reduced to half that of the enzyme ac-
tivity in the same concentration of DEA. Water was not a 
strong enough nucleophile to sufficiently pull the phosphorus 
atom away from serine; unlike DEA which was a stronger nu-
cleophile. 
The removal of the phosphate from the phosphoryl-enzyme 
22 
Fig. 6. Proposed alkaline phosphatase mechanism 
E = Alkaline phosphatase 
p-NPP = para-Nitrophenyl phosphate 
p-NP = para-Hitrophenol 
ROH = Nucleophile 
2.3 
pNPP pNP ROH RO~ 
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by the nucleophile is the rate determining step for the over-
all reaction. The enzyme must become dephosphorylated be-
fore it can again interact with the substrate. The inhibi-
tor seems to affect this step in the reaction. The inhibi-
tor by combining with the phosphoryl-enzyme-substrate complex 
may prevent the transfer of the phosphate from the enzyme to 
the nucleophile but not interfere with the release of the de-
phosphorylated substrate (product). The amount of product 
formed gradually diminishes as more inhibitor molecules pre-
vent dephosphorylation of the enzyme which reduces the amount 
of free enzyme available to interact with substrate. 
L-Homoarginine competes with DEA for the phosphoryl-
enzyme complex in high DEA concentrations. The inhibitor 
may be combining with more than one enzyme form to produce a 
mixed mechanism in low DEA concentrations since there are 
fewer DEA molecules complexed with the phosphorylated enzyme. 
Although the inhibition of APase by L-homoarginine ap-
pears to be uncompetitive and the inhibitor is not a sub-
strate analog; the structure of the amino acid inhibitor may 
be critical. The active site of the enzyme probably has a 
hydrophobically charged environment since amino acids with un-
charged polar groups produced the least inhibition. Amino 
acids with nonpolar groups collectively had increased influ-
ence over this group on reducing the enzyme activity. Amino 
acids that contained branched hydrocarbon chains including 
isoleucine, valine and leucine, in1ibited the greatest.in 
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the nonpolar group. The amount of inhibition increased con-
siderably when the methyl group was shifted in the hydrocar-
bon chain from the alpha position in isoleucine to the beta 
position in leucine. The inhibitory effect was also slight-
ly increased when the hydrocarbon chain was lengthened from 
three carbons in valine to four carbons in leucine, even 
though the degree of branching had not changed. The amount 
of inhibition by amino acids having basic groups increased 
with the basicity of the constituent. An increase in the 
carbon length of arginine by a single methyl group produced 
amazing differences in the percent inhibition by arginine 
(38.69%) and homoarginine (77.22%). Changes in the terminal 
basic group from amide to carboxyl reduced the APase inhibi-
tion. These basic amino acids, because of their inhibition, 
may indicate the existence of acidic groups deep within the 
enzyme molecule. Increased inhibition by the elongation of 
the carbon chain may be due to the increased ability of the 
basic groups to extend deeper into the enzyme molecule to 
combine with these acidic groups. 
Alkaline phosphatase inhibition by amino acids appears 
to be dependent on the type substrate used in the assay. 
The enzyme undergoes certain modifications while interacting 
with the substrate; assuming Koshland 1 s "induced fit" hypo-
thesis is true. The subatituents of the substrates would 
therefore influence the modifications made by the enzyme. 
These differences that exlst in the enzyme from substrate to 
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substrate do not make a drastic change in the overall effi-
ciency of the enzyme to form product, but may become a fac-
tor in the binding of the inhibitor to the enzyme-substrate 
complex. The binding affinity between enzyme and a parti-
cular substrate may force the APase molecule into a con-
formation that would allow a site for an inhibitor, while 
a different substrate may cause a conformation that excludes 
that same inhibitor. This theory explains why different 
results were obtained in inhibition studies according to the 
type substrate employed. 
Fishman's group found human placental APase was not in-
hibited by L-homoarginine using phenyl phosphate as a sub-
strate. Although no inhibition occured in the placental 
isozyme; they found human bone and liver isozymes of APase 
were inhibited 73% by L-homoarginine. This figure compares 
favorably to the 77% inhibition of murine placental APase by 
L-homoarginine obtained in these experiments using p-NPP as 
the substrate. Further studies are needed to compare the in-
hibition of human and murine APase by amino acids in order to 
determine if inhibition differences are due to species speci-
ficity and whether any substrate specificity exists among 
these APase isozymes. 
CHAPrER VI 
SUMMARY 
1. L-Amino acids containing basic groups created the great-
est inhibition of APase activity. 
2. L-Homoarginine performs "uncompetitivel.y" in the APase 
reaction affecting the enzyme-substrate complex. 
3· Diethanolamine, a nucleophilic activating buffer in high 
concentrations acts "competitively" against L-homoargi-
nine. 
4• Alkaline phosphatase undergoes a ping pong bi bi mecha-
nism in which it clemonstrates phosphoh7d.rolase activ:l.ty 
toward the first substrate and transphosphorylase or 
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